Efficacy and Safety of Telitacicept in IgAN

Clinical trial NCT06654596 · RECRUITING

Trial details

NCT number: NCT06654596
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

IgA Nephropathy (IgAN)Kidney Diseases Telitacicept Glucocorticoid

Start date: 2024-12-06
Primary completion: 2026-12-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.